Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosus

Lupus · Published 2026-06-01 · DOI 10.1177/09612033261458427

Authors (2)

Eleonora Castellana, Maria Rachele Chiappetta

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Castellana, E., Chiappetta, M. (2026). Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosus. Lupus. https://doi.org/10.1177/09612033261458427

Related articles

• Unusual triad in systemic lupus erythematosus: Alopecia, pigmentation, and keratoderma · Lupus · 2026 · Same journal
• Continuation of belimumab in patients with systemic lupus erythematosus in a real-world setting: A single-center retrospective cohort study · Lupus · 2026 · Same journal
• Real-world use of anifrolumab in systemic lupus erythematosus: A retrospective study from a Danish tertiary center (2022–2025) · Lupus · 2026 · Same journal
• Frequency and clinical associations of Epstein-Barr virus molecular detection in systemic lupus erythematosus: A follow-up study · Lupus · 2026 · Same journal
• Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus · Lupus · 2026 · Same journal
• Linear/arciform blaschkoid lupus erythematosus tumidus of the face – An extremely rare clinical manifestation · Lupus · 2026 · Same journal
• Factors associated with changes in self-efficacy in patients with systemic lupus erythematosus. Data from the almenara lupus cohort · Lupus · 2026 · Same journal
• Long-term outcomes of patients with moderate-severe pediatric systemic lupus erythematosus treated with combination rituximab and cyclophosphamide therapy: A single center cohort experience and review of literature · Lupus · 2026 · Same journal
• Serum C-reactive protein levels can predict organ damage in patients with SLE with the lupus low disease activity state · Lupus · 2026 · Same journal
• Association between interstitial fibrosis/tubular atrophy (IFTA) on kidney biopsies and anti Ro60 antibody positivity in patients with lupus nephritis (LN) · Lupus · 2026 · Same journal